FDA May Require Premarket Clearance For Exact Sciences’ PreGen-Plus

LabCorp will continue to market Exact Sciences' PreGen-Plus colorectal cancer screening assay pending further word from FDA, which has indicated that the diagnostic may require regulation as a medical device, Exact Sciences says